Clinical Trial: SANGUINATE™ in Sickle Cell Disease Associated Leg Ulcer

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: An Open-label, Repeated-dose, Dose Escalation Study of the Safety and Effectiveness of SANGUINATE™ for the Treatment of Leg Ulcers in Adult Patients With Sickle Cell

Brief Summary: SANGUINATE™ Sickle Cell Disease associated Leg Ulcers.